worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Newsroom

Novartis Newsroom

PrinttextDecrease text sizeIncrease text size

Media releases

Select a language: en | de | fr

Select a year: 2008 | 2007

December 04, 2008

''Dare to dialog?'' - experts debate on the conditions of constructive stakeholder relations at this year's symposium of the Novartis Foundation for Sustainable Development

 

 

December 04, 2008

More than 200 abstracts at ASH and SABCS reveal potential compelling patient benefits from Novartis Oncology current and pipeline therapies

 

 

November 21, 2008

Sandoz receives positive EU opinion for biosimilar filgrastim

 

 

November 21, 2008

Rasilez HCT® receives recommendation for European approval as a single-pill combination to treat high blood pressure

 

 

November 19, 2008

Novartis highlights innovative approach to drug discovery with dynamic advance in exploratory pipeline

 

 

November 11, 2008

Rasilez®, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than ACE inhibitor ramipril in patients 65 and older

 

 

October 29, 2008

Rasilez HCT®, single-pill combination of Rasilez® and diuretic, receives Swiss approval for the treatment of high blood pressure

 

 

October 27, 2008

ACZ885 Phase III data show rapid, sustained clinical remission in children and adults suffering from a group of rare, potentially life-threatening autoinflammatory diseases

 

 

October 21, 2008

Novartis to acquire Nektar Therapeutics pulmonary business unit, strengthening respiratory drug delivery capabilities

 

 

October 20, 2008

Novartis delivers sustained strong performance in first nine months of 2008 underpinned by accelerating growth in pharmaceuticals

 

‹   1-10   11-20   21-30   ›  

87 Total results

 

The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

SWX

NYSE

 
 

NOVZn

See stock performance

 
 

NVS

See stock performance

Event calendar

Find out about upcoming events for shareholders.

View event calendar

Get Novartis Media Releases through RSS


Stay Connected

Receive updates on company news and announcements.

Sign up for newsfeeds